Kovacs C S, Ralston S H. Presentation and management of osteoporosis presenting in association with pregnancy or lactation. Osteoporos Int 2015;26:2223-41.
Albright F, Reifenstein E. The parathyroid glands and metabolic bone disease. Ulster Med J 1950;19:130-1.
Campos-Obando N, Oei L, Hoefsloot L H, Kiewiet R M, Klaver C C W, Simon M E H, et al. Osteoporotic vertebral fractures during pregnancy: be aware of a potential underlying genetic cause. J Clin Endocrinol Metab 2014;99:1107-11.
Nelson Piercy C. Heparin-induced osteoporosis. Scand J Rheumatol Suppl.1998;107:68-71.
Lefkou E et al. Review: Low-molecular-weight heparin-induced osteoporosis and osteoporotic fractures: a myth or an existing entity? Lupus 2010 Jan;19:3-12.
Plige H et al. Enoxaparin and rivaroxaban have different effects on human mesenchymal stromal cells in the early stages of bone healing. Bone Joint Res 2016 Mar;5:95-100.
Kovacs C S. Osteoporosis presenting in pregnancy, puerperium, and lactation. Curr Opinion Endocrinol Diabetes Obes 2014;1:468-75.
Choe E Y, Song J E, Park K H, Seok H, Lee E J, Lim S K, Rhee Y. Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures. J Bone Miner Metab 2012;30:596-601.